Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin

Clinical Cancer Research

Volumn 5, Issue 11, 1999, Pages 3352-3356

  Abolhoda, Amir ^a   Wilson, Amy E ^a   Ross, Howard ^a   Danenberg, Peter V ^b   Burt, Michael ^a   Scotto, Kathleen W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; LUNG METASTASIS; LUNG PERFUSION; MALE; MULTIDRUG RESISTANCE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA;

EID: 0032713821     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ling, V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol., 40: S3-S8, 1997.
2. Fardel, O., Lecureur, V., and Guillouzo, A. The P-glycoprotein multidrug transporter. Gen. Pharmacol., 27: 1283-1291, 1996.
3. Dalton, W. S. Mechanisms of drug resistance in hematologic malignancies. Semin. Hematol., 34: 3-8, 1997.
4. Baldini, N., Scotlandi, K., Barbanti-Brodano, G., Manara, M. C., Maurici, D., Bacci, G., Bertoni, F., Picci, P., Sottili, S., Campanacci, M., and Serra, M. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N. Engl. J. Med., 333: 1380-1385, 1995.
5. Gregorcyk, S., Kang, Y., Brandt, D., Kolm, P. Singer, G., and Perry, R. R. P-glycoprotein expression as a predictor of breast cancer recurrence. Ann. Surg. Oncol., 3: 8-14, 1996.
6. Chan, H. S., Thorner, P. S., Haddad, G., and Ling, V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol., 8: 689-704, 1990.
7. Willman, C. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program. Semin. Hematol., 34 (4 Suppl. 5): 25-33, 1997.
8. Chin, K. V., Chauhan, S. S., Pastan, I., and Gottesman, M. M. Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Differ., 1: 361-365, 1990.
9. Chaudhary, P. M., and Roninson, I. B. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl. Cancer Inst. 85: 632-638, 1993.
10. Hu, X. F., Slater, A., Wall, D. M., Kantharidis, P., Parkin, J. D., Cowman, A., and Zalcberg, J. R. Rapid up-regulation of MDR1 expression by anthracyclines in a classical multidrug-resistant cell line. Br. J. Cancer, 71: 931-936, 1995.
11. Tomida, A., Naito, M., and Tsuruo, T. Acute induction of Adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of Adriamycin. Jpn. J. Cancer Res., 86: 224-232, 1995.
12. Weksler, B., Ng, B., Lenert, J. T., and Burt, M. E. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann. Thorac. Surg., 56: 209-214, 1993.
13. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
14. Horikoshi, T., Danenberg, K. D. Stadlbauer, T. H., Volkenandt, M., Shea, L. C., Aigner, K., Gustavsson, B., Leichman, L., Prosing, R., Ray, M., Gibson, N. W., Spears, C. P., and Danenberg, P. V. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
15. Kuo, D. Y. S., Mallick, S., Shen, H-J., DeVictoria, C., Jones, J., Fields, A. L., Goldberg, G. L., Runowicz, C. D., and Horwitz, S. B. Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry. Clin. Cancer Res., 2: 1981-1992, 1996.
16. Scotto, K. W., and Bertino, J. R. Chemotherapy susceptibility and resistance, In: J. Mendelsohn (ed.), Molecular Basis of Cancer Therapy, pp. 468-485. Philadelphia: W. B. Saunders, 1995.
17. Egan, D. A., and Scotto, K. W. Transcriptional regulation of multidrug-resistance genes. In: M. Clynes (ed.), Cytotechnology: International Journal of Cell Culture and Biotechnology. Vol. 27, pp. 257-269. Dordrecht, the Netherlands: Kluwer, 1998.
18. Hu, Z., Jin, S, and Scotto, K. W. Transcriptional activation of the MDR1 gene by UV irradiation and chemotherapeutics: role of NF-Y and SP factors. Proc. Am. Assoc. Cancer Res., 1999.
19. Weksler, B., Ng, B., Lenert, J. T., and Burt, M. E. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann. Thorac. Surg., 56: 209-214, 1993.
20. Sikic, B. I., Fisher, G. A., Lum, B. L., Halsey, J., Beketic-Oreskovic, L., and Chen, G. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother. Pharmacol., 40: S13-S19, 1997.